$143 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 327 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LIN | LINDE PLC | $83,342,000 | +6.3% | 297,500 | 0.0% | 0.06% | 0.0% | |
LVS | LAS VEGAS SANDS CORP | $71,022,000 | +1.9% | 1,168,900 | 0.0% | 0.05% | -3.8% | |
LHX | L3HARRIS TECHNOLOGIES INC | $65,830,000 | +7.2% | 324,800 | 0.0% | 0.05% | 0.0% | |
ROCK | GIBRALTAR INDS INC | $34,307,000 | +27.2% | 374,900 | 0.0% | 0.02% | +20.0% | |
LPLA | LPL FINL HLDGS INC | $29,001,000 | +36.4% | 204,000 | 0.0% | 0.02% | +25.0% | |
ATUS | ALTICE USA INCcl a | $27,221,000 | -14.1% | 836,800 | 0.0% | 0.02% | -20.8% | |
NVT | NVENT ELECTRIC PLC | $24,781,000 | +19.8% | 887,900 | 0.0% | 0.02% | +13.3% | |
ULTA | ULTA BEAUTY INC | $23,281,000 | +7.7% | 75,300 | 0.0% | 0.02% | 0.0% | |
FOLD | AMICUS THERAPEUTICS INC | $21,044,000 | -57.2% | 2,130,000 | 0.0% | 0.02% | -59.5% | |
SCOR | COMSCORE INC | $20,086,000 | +47.0% | 5,487,965 | 0.0% | 0.01% | +40.0% | |
GSK | GLAXOSMITHKLINE PLCsponsored adr | $19,961,000 | -3.0% | 559,300 | 0.0% | 0.01% | -6.7% | |
ARE | ALEXANDRIA REAL ESTATE EQ IN | $19,634,000 | -7.8% | 119,500 | 0.0% | 0.01% | -12.5% | |
CVGW | CALAVO GROWERS INC | $14,239,000 | +11.8% | 183,400 | 0.0% | 0.01% | +11.1% | |
PM | PHILIP MORRIS INTL INC | $13,755,000 | +7.2% | 155,000 | 0.0% | 0.01% | 0.0% | |
SAIC | SCIENCE APPLICATIONS INTL CO | $14,026,000 | -11.7% | 167,800 | 0.0% | 0.01% | -16.7% | |
SREV | SERVICESOURCE INTL INC | $12,302,000 | -16.5% | 8,368,633 | 0.0% | 0.01% | -18.2% | |
MGNI | MAGNITE INC | $12,483,000 | +35.5% | 300,000 | 0.0% | 0.01% | +28.6% | |
DRI | DARDEN RESTAURANTS INC | $7,356,000 | +19.2% | 51,800 | 0.0% | 0.01% | 0.0% | |
TWOU | 2U INC | $6,488,000 | -4.4% | 169,700 | 0.0% | 0.01% | 0.0% | |
FARO | FARO TECHNOLOGIES INC | $6,527,000 | +22.5% | 75,400 | 0.0% | 0.01% | +25.0% | |
PS | PLURALSIGHT INC | $4,231,000 | +6.6% | 189,400 | 0.0% | 0.00% | 0.0% | |
BOOT | BOOT BARN HLDGS INC | $4,673,000 | +43.7% | 75,000 | 0.0% | 0.00% | +50.0% | |
NFLX | NETFLIX INC | $2,869,000 | -3.5% | 5,500 | 0.0% | 0.00% | 0.0% | |
HOME | AT HOME GROUP INC | $3,217,000 | +85.6% | 112,100 | 0.0% | 0.00% | +100.0% | |
GIL | GILDAN ACTIVEWEAR INC | $3,322,000 | +9.5% | 108,340 | 0.0% | 0.00% | 0.0% | |
AXP | AMERICAN EXPRESS CO | $2,659,000 | +17.0% | 18,800 | 0.0% | 0.00% | 0.0% | |
MREO | MEREO BIOPHARMA GROUP PLCads | $1,648,000 | -5.9% | 489,100 | 0.0% | 0.00% | 0.0% | |
ANET | ARISTA NETWORKS INC | $951,000 | +3.9% | 3,150 | 0.0% | 0.00% | 0.0% | |
ABUS | ARBUTUS BIOPHARMA CORP | $1,665,000 | -6.2% | 500,000 | 0.0% | 0.00% | 0.0% | |
GEFB | GREIF INCcl b | $1,889,000 | +18.3% | 33,000 | 0.0% | 0.00% | 0.0% | |
CE | CELANESE CORP DEL | $1,640,000 | +15.2% | 10,950 | 0.0% | 0.00% | 0.0% | |
TXG | 10X GENOMICS INC | $1,385,000 | +27.9% | 7,650 | 0.0% | 0.00% | 0.0% | |
MSGS | MADISON SQUARE GRDN SPRT CORcl a | $1,233,000 | -2.5% | 6,873 | 0.0% | 0.00% | 0.0% | |
CERN | CERNER CORP | $1,394,000 | -8.5% | 19,400 | 0.0% | 0.00% | 0.0% | |
PBH | PRESTIGE CONSMR HEALTHCARE I | $1,384,000 | +26.4% | 31,400 | 0.0% | 0.00% | 0.0% | |
VLRS | CONTROLADORA VUELA COMP DE Aspon adr rp 10 | $1,027,000 | +14.9% | 72,000 | 0.0% | 0.00% | 0.0% | |
AWI | ARMSTRONG WORLD INDS INC NEW | $1,982,000 | +21.1% | 22,000 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
BIOGEN INC. | 42 | Q3 2023 | 6.8% |
AMGEN INC. | 42 | Q3 2023 | 5.3% |
MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
FEDEX CORP | 42 | Q3 2023 | 3.3% |
SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
NN INC | November 09, 2022 | 1,763,640 | 4.0% |
AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.